These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 9509276)

  • 1. Dyspepsia: current understanding and management.
    Agréus L; Talley NJ
    Annu Rev Med; 1998; 49():475-93. PubMed ID: 9509276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modern management of dyspepsia.
    Talley NJ
    Aust Fam Physician; 1996 Jan; 25(1):47-52. PubMed ID: 8607775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional dyspepsia: definition, classification, clinical and therapeutic management].
    Montalto M; Santoro L; Vastola M; Curigliano V; Cammarota G; Manna R; Gasbarrini G
    Ann Ital Med Int; 2004; 19(2):84-9. PubMed ID: 15317268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the management of dyspepsia.
    Talley NJ; Vakil N;
    Am J Gastroenterol; 2005 Oct; 100(10):2324-37. PubMed ID: 16181387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to manage the dyspeptic patient.
    Vaira D
    Helicobacter; 1996 Dec; 1(4):261-2. PubMed ID: 9398879
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.
    Sonnenberg A
    Am J Gastroenterol; 1996 Sep; 91(9):1773-7. PubMed ID: 8792696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of Helicobacter pylori eradication on chronic use of acid-suppressant medication by patients in general practice; a randomised, double-blind study].
    Hurenkamp GJ; Grundmeijer HG; van der Ende A; Tytgat GN; Assendelft WJ; van der Hulst RW
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2390-6. PubMed ID: 15615275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
    McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A
    Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyspepsia and Helicobacter pylori.
    Selgrad M; Kandulski A; Malfertheiner P
    Dig Dis; 2008; 26(3):210-4. PubMed ID: 18463437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dyspepsia in the elderly. Initial endoscopy or empirical therapy?].
    Nordmann A; Friesewinkel O; Scheurer U; Gyr K
    Dtsch Med Wochenschr; 1998 Apr; 123(18):577-80. PubMed ID: 9615699
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyspepsia, peptic ulcer, and H. pylori: a remembrance of things past.
    Vakil N
    Am J Gastroenterol; 2010 Mar; 105(3):572-4. PubMed ID: 20203639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical practice guideline on the management of patients with dyspepsia. Update 2012].
    Gisbert JP; Calvet X; Ferrándiz J; Mascort J; Alonso-Coello P; Marzo M;
    Gastroenterol Hepatol; 2012 Dec; 35(10):725.e1-38. PubMed ID: 23186826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are dyspepsia management guidelines coherent with primary care practice?
    Cardin F; Zorzi M; Furlanetto A; Guerra C; Bandini F; Polito D; Bano F; Grion AM; Toffanin R
    Scand J Gastroenterol; 2002 Nov; 37(11):1269-75. PubMed ID: 12465724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.
    Groeneveld PW; Lieu TA; Fendrick AM; Hurley LB; Ackerson LM; Levin TR; Allison JE
    Am J Gastroenterol; 2001 Feb; 96(2):338-47. PubMed ID: 11232673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
    Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
    Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.